Bristol-Myers Squibb CoBSP:BMYB34 +2.49%71 OCF Yield % is 11.73 as of Jun. 24, 2026, which is 25% above its 10-year median of 9.39. GuruFocus rates BSP:BMYB34 with a GF Score™ of 71/100 and a GF Value™ of R$274.39 (Fairly Valued). The stock has 4 warning signs investors should review. Among 1,005 Drug Manufacturers companies, Bristol-Myers Squibb Co ranks better than 82.79% on this metric.
OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.
Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Bristol-Myers Squibb Co OCF Yield % Related Terms
Bristol-Myers Squibb Co OCF Yield % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BSP:BMYB34 vs PFE, GILD, AMGN: OCF Yield % Comparison
For the Drug Manufacturers - General subindustry, Bristol-Myers Squibb Co's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bristol-Myers Squibb Co OCF Yield % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Bristol-Myers Squibb Co's OCF Yield % distribution charts can be found below:
* The bar in red indicates where Bristol-Myers Squibb Co's OCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bristol-Myers Squibb Co (BSP:BMYB34) has a OCF Yield % of 11.73 as of Jun. 24, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Bristol-Myers Squibb Co and its competitors. This is 25% above median its historical median of 9.39. Over the past decade, Bristol-Myers Squibb Co's OCF Yield % has ranged from 1.27 to 18.68. According to the industry distribution chart, Bristol-Myers Squibb Co ranks #173 out of 1005 companies in the Drug Manufacturers industry, placing it in the top 17.2%.
Is Bristol-Myers Squibb Co's OCF Yield % too high?
Bristol-Myers Squibb Co's current OCF Yield % of 11.73 is 25% above median its 10-year median of 9.39. Over the past 10 years, this metric has ranged from a low of 1.27 to a high of 18.68. The Drug Manufacturers industry median OCF Yield % is 3.54. Bristol-Myers Squibb Co's value of 11.73 is 231.4% above this industry median. Based on the distribution chart, Bristol-Myers Squibb Co ranks #173 out of 1005 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Bristol-Myers Squibb Co has a GF Score™ of 71/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Bristol-Myers Squibb Co's OCF Yield % compare to PFE and GILD?
According to the Drug Manufacturers industry distribution chart, Bristol-Myers Squibb Co ranks #173 out of 1005 companies for OCF Yield %. This places Bristol-Myers Squibb Co in the top 17% of its industry — outperforming the majority of peers. The industry median OCF Yield % is 3.54. Bristol-Myers Squibb Co's value of 11.73 is 231.4% above this benchmark. Historically, Bristol-Myers Squibb Co's own OCF Yield % has ranged from 1.27 to 18.68 over the past decade. While the company's 10-year median is 9.39 vs. the industry median of 3.54, Bristol-Myers Squibb Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Drug Manufacturers company?
The median OCF Yield % among Drug Manufacturers companies is 3.54, based on 1,005 companies in the industry. Companies in the top quartile (top 25%) have a OCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Bristol-Myers Squibb Co's current OCF Yield % of 11.73 is 231.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Bristol-Myers Squibb Co and its competitors. For the Drug Manufacturers industry, the median OCF Yield % is 3.54 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bristol-Myers Squibb Co's current OCF Yield % is 11.73, which is 25% above median its own 10-year median of 9.39. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bristol-Myers Squibb Co stock overvalued right now?
Based on GuruFocus' analysis, Bristol-Myers Squibb Co (BSP:BMYB34) is currently considered Fairly Valued. The stock's GF Value™ is R$274.39, compared to a current price of R$287.84 — trading 4.9% above its estimated fair value. The current OCF Yield % is 11.73, which is 25% above median its 10-year median of 9.39 and 231.4% above the Drug Manufacturers industry median of 3.54. Bristol-Myers Squibb Co's overall GF Score™ is 71/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For Bristol-Myers Squibb Co (BSP:BMYB34), the current OCF Yield % is 11.73 as of Jun. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bristol-Myers Squibb Co (BSP:BMYB34) Overvalued in 2026?
Based on GuruFocus' analysis, Bristol-Myers Squibb Co stock appears to be overvalued.
The current stock price of R$287.84 is trading 4.9% above its estimated GF Value™ of R$274.39.
GuruFocus considers Bristol-Myers Squibb Co to be Fairly Valued.
Key valuation signals for BSP:BMYB34:
OCF Yield %: 11.73 (25% above median its 10-year median of 9.39)
GF Value™: R$274.39 vs. price of R$287.84 (4.9% above fair value)
Industry Position: 231.4% above the Drug Manufacturers median (#173 of 1005)
No single metric tells the full story. See the BSP:BMYB34 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Bristol Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.
71GF Score
Get the complete analysis for BSP:BMYB34
OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BSP:BMYB34 has been successfully added to your 
